Evaluation of floating and sticking extended release delivery systems:: an unconventional dissolution test

被引:41
作者
Dürig, T [1 ]
Fassihi, R [1 ]
机构
[1] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA
关键词
USP apparatus I and II; hydrodynamics; double mesh device; hydrophilic matrix tablets;
D O I
10.1016/S0168-3659(00)00194-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The extent to which hydrophilic matrix tablets with a propensity to stick to the dissolution apparatus and/or float are susceptible to variations in hydrodynamic conditions during dissolution testing was investigated. Furthermore the usefulness of simple alternatives to the current compendial tests is examined. Swellable hydrocolloid (guar) matrix tablets containing verapamil HCl were evaluated using USP dissolution apparatus I and II. Two additional configurations where an additional single ring and mesh device or a double mesh device was located below the paddle in the dissolution vessel were also evaluated. Tablets were placed on top of the single mesh device or in the compartment formed by the two mesh surfaces of the double mesh device. In all cases near linear (n greater than or equal to 0.82) release profiles were observed. When using apparatus I it was observed that the highly swellable tablets were fully constricted by the basket within 5-7 h. This prevented further independent movement and unimpeded swelling and coincided with a departure from linear release and increased variability (S.D.less than or equal to 9.5%). Under standard apparatus II conditions two out of three tablets adhered to the bottom of the dissolution vessel for the duration of the experiment. Consequently their release profiles differed markedly from those obtained under apparatus I conditions (similarity factor, f(2)=30.5) with the release rate being approximately half of that obtained under apparatus I conditions. Adhesion to the dissolution vessel was also observed when paddle speed was doubled to 100 rpm, thus again resulting in large variability (S.D.less than or equal to 34%). Whilst the averaged single and double mesh configuration profiles were similar to the apparatus I profile (f(2)=57.36 and 61.38, respectively), large variability (S.D.less than or equal to 11%) occurred with the single mesh configuration due to floating and random adhesion of tablets to the paddle or sampling tubes. Almost superimposable profiles were obtained for the individual tablets (S.D.<3%) when the tablets were located in the compartment formed by the double mesh device. Use of a double mesh device may therefore provide an alternative to current compendial dissolution methods when the reliable determination of the true release kinetics of floating and sticking delivery systems is desired. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 13 条
[1]  
Beckett A. H., 1996, Dissolut. Technol., V2, P7, DOI [10.14227/DT030296P7, DOI 10.14227/DT030296P7]
[2]  
BECKETT AH, 1996, DISSOLUTION TECHNOL, V3, P18
[3]   FLUID AND PARTICLE LASER DOPPLER VELOCITY-MEASUREMENTS AND MASS-TRANSFER PREDICTIONS FOR THE USP PADDLE METHOD DISSOLUTION APPARATUS [J].
BOCANEGRA, LM ;
MORRIS, GJ ;
JUREWICZ, JT ;
MAUGER, JW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (09) :1441-1464
[4]   The effect of cross-linking on the in vivo disintegration of hard gelatin capsules [J].
Brown, J ;
Madit, N ;
Cole, ET ;
Wilding, IR ;
Cadé, D .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1026-1030
[5]   Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs [J].
Galia, E ;
Nicolaides, E ;
Hörter, D ;
Löbenberg, R ;
Reppas, C ;
Dressman, JB .
PHARMACEUTICAL RESEARCH, 1998, 15 (05) :698-705
[6]   Modeling of drug release from erodible tablets [J].
Katzhendler, I ;
Hoffman, A ;
Goldberger, A ;
Friedman, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :110-115
[7]   DRUG-RELEASE FROM HYDROCOLLOID EMBEDDINGS WITH HIGH OR LOW SUSCEPTIBILITY TO HYDRODYNAMIC STRESS [J].
LINDNER, WD ;
LIPPOLD, BC .
PHARMACEUTICAL RESEARCH, 1995, 12 (11) :1781-1785
[8]  
Members of the Gelatin Capsule Working Group, 1998, PHARMACOPEIAL FORUM, V24, P7045
[9]  
Moore J.W., 1996, PHARM TECHNOL, V20, P64, DOI DOI 10.1017/CCOL521633230.011
[10]   Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method [J].
Pillay, V ;
Fassihi, R .
JOURNAL OF CONTROLLED RELEASE, 1998, 55 (01) :45-55